Related Experiment Videos
Pouch drug delivery systems for dermal and transdermal administration
1The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, PO box 12065, Jerusalem, 91120, Israel.
Drug Delivery and Translational Research
|March 20, 2015
Summary
Researchers developed novel pouch drug delivery systems (PDDS) using ethanol, phospholipids, and polymers for enhanced dermal and transdermal drug delivery. These non-irritant systems show improved drug permeation and prolonged therapeutic effects.
Area of Science:
- Pharmaceutical Sciences
- Materials Science
Background:
- Dermal and transdermal drug delivery systems are crucial for effective treatment administration.
- Existing systems face challenges in drug permeation, stability, and patient compliance.
Purpose of the Study:
- To design and investigate a novel carrier system for enhanced dermal and transdermal drug delivery.
- To characterize the physicochemical properties and evaluate the efficacy of the new system.
Main Methods:
- Development of pouch drug delivery systems (PDDS) using high ethanol concentration, phospholipid, polymer, and water.
- Characterization of the PDDS matrix using electron microscopy, (31)P-NMR, and FTIR.
- Pharmacodynamic evaluation of PDDS with lidocaine, brotizolam, and ibuprofen in relevant models and non-irritancy testing on a skin model.
Main Results:
- The PDDS formed a structured matrix upon non-occluded application to the skin.
- Lidocaine PDDS demonstrated faster drying and enhanced dermal delivery compared to a clinical product.
- PDDS with brotizolam and ibuprofen showed prolonged hypnotic and antipyretic effects, respectively.
- The carrier system was found to be non-irritant.
Conclusions:
- The developed pouch drug delivery systems (PDDS) offer a promising platform for improved dermal and transdermal drug administration.
- The system's properties, including enhanced drug delivery and prolonged effects, support its potential for various therapeutic applications.
- The non-irritant nature of the PDDS further enhances its suitability for clinical use.